FDA Adverse Event Injury Summary report: N

COMPLETE SE SFA

MDR report key: 4299354 · Received December 5, 2014

Report

Report Number
9612164-2014-01599
Event Type
Injury
Date Received
December 5, 2014
Date of Event
December 1, 2014
Report Date
December 8, 2014
Manufacturer
MEDTRONIC IRELAND
Product Code
NIP
PMA / PMN Number
P110040
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

EVALUATION, RESULTS - INHERENT RISK OF PROCEDURE (OCCLUSION/RESTENOSIS).

Additional Manufacturer Narrative · 1

(B)(4). EVALUATION RESULTS: INHERENT RISK OF PROCEDURE (OCCLUSION OF SFA ARTERY OR DISTAL VASCULATURE). EVALUATION CONCLUSION: KNOWN INHERENT RISK OF PROCEDURE (OCCLUSION OF SFA ARTERY OR DISTAL VASCULATURE).

Description of Event or Problem · 1

APPROXIMATELY 19 MONTHS POST INDEX PROCEDURE A REVASCULARIZATION OF THE RIGHT SFA WAS PERFORMED TO TREAT THE PREVIOUSLY REPORTED RIGHT SFA RE-OCCLUSION EVENT APPROXIMATELY 18 MONTHS POST INDEX PROCEDURE. 2 NON MEDTRONIC BALLOONS, 2 PACIFIC PLUS BALLOONS, ONE IN.PACT PACIFIC BALLOON AND A NON MEDTRONIC STENT WERE USED AS TREATMENT.

Description of Event or Problem · 1

DURING INDEX PROCEDURE A COMPLETE SE PERIPHERAL STENT WAS USED TO TREAT A LESION LOCATED IN THE SFA OF THE RIGHT LEG. APPROXIMATELY 12 MONTHS LATER IT IS REPORTED THAT THE PATIENT SUFFERED FROM RESTENOSIS OF THE R.SFA. INVESTIGATOR INDICATED THE EVENT WAS NOT RELATED TO THE DEVICE OR PROCEDURE. EVENT IS CONTINUING. APPROXIMATELY 18 MONTHS POST THE INDEX PROCEDURE IT IS REPORTED THAT THE PATIENT SUFFERED FROM RE-OCCLUSION OF THE R.SFA. EVENT IS CONTINUING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
788311 COMPLETE SE SFA STENT, SUPERFICIAL FEMORAL ARTERY NIP MEDTRONIC IRELAND

Patients

Seq Age Sex Outcome Treatment
1 00067 YR Hospitalization| R